Amedeo's Top 20

Amedeo Smart

Independent Medical Education


14 February 2022

Multidisciplinary Journal Club

  1. Hacisuleyman E, Hale C, Saito Y, Blachere NE, et al.
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med 2021.

  1. Spigel DR, Faivre-Finn C, Gray JE, Vicente D, et al.
    Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
    J Clin Oncol 2022.

  2. Bikdeli B, Garcia DA.
    In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
    Ann Intern Med 2022.

  3. Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, et al.
    Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
    J Clin Oncol 2022.

  4. Anderson DN, Port ER.
    Surgery No More? Managing the Primary Tumor in Stage IV Breast Cancer.
    J Clin Oncol 2022.

  1. Cleveland NK, Torres J, Rubin DT.
    WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?
    Gastroenterology 2022.

  2. Wymant C, Bezemer D, Blanquart F, Ferretti L, et al.
    A highly virulent variant of HIV-1 circulating in the Netherlands.
    Science 2022;375:540-545.

  3. Davidson KW, Barry MJ, Mangione CM, Cabana M, et al.
    Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.
    JAMA 2022;327:360-367.

  4. Jang H, Lee YB, Moon H, Chung JW, et al.
    Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis.
    Hepatology 2022.

  5. Alcala C, Quintanilla-Bordas C, Gascon F, Sempere AP, et al.
    Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
    J Neurol 2022.

  1. Oguz SH, Sendur SN, Iremli BG, Gurlek A, et al.
    SARS-CoV-2 vaccine-induced thyroiditis: Safety of Re-vaccinations and Clinical Follow-up.
    J Clin Endocrinol Metab 2022.

  2. Paramanandam VS, Dylke E, Clark GM, Daptardar AA, et al.
    Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
    J Clin Oncol 2022.

  3. Gil YE, Lee MJ, Cho S, Chung CS, et al.
    Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine.
    Headache 2022.

  4. Keeton R, Tincho MB, Ngomti A, Baguma R, et al.
    T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
    Nature 2022.

  5. Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, et al.
    Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.
    Ann Intern Med 2022.

  1. Lublin FD, Haring DA, Ganjgahi H, Ocampo A, et al.
    How patients with multiple sclerosis acquire disability.
    Brain 2022.

  2. Huber H, Edenhofer S, von Tresckow J, Robrecht S, et al.
    Phase 2 study of obinutuzumab (GA-101), ibrutinib and venetoclax (CLL2-GIVe) in patients with untreated high-risk chronic lymphocytic leukemia.
    Blood 2021.

  3. Morrison SL, Han G, Elenwa F, Vetto JT, et al.
    Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
    Cancer 2022.

  4. Tortorella C, Aiello A, Gasperini C, Agrati C, et al.
    Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
    Neurology 2022;98:e541-e554.

  5. Rivard L, Friberg L, Conen D, Healey JS, et al.
    Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
    Circulation 2022;145:392-409.


more..


Privacy Policy